neurogenetics

, Volume 12, Issue 4, pp 325–332

Homozygosity for the MTX1 c.184T>A (p.S63T) alteration modifies the age of onset in GBA-associated Parkinson's disease

  • Ziv Gan-Or
  • Anat Bar-Shira
  • Tanya Gurevich
  • Nir Giladi
  • Avi Orr-Urtreger
ORIGINAL ARTICLE

Abstract

A strong association was established between the GBA gene and Parkinson's disease (PD) worldwide. The most frequent GBA mutation among the Ashkenazi population (p.N370S) was previously associated with the c.1051T>C (p.F351L) alteration in the closely located MTX1 gene. We further studied the association between these two genes and its possible effect on PD. The entire coding region and exon–intron boundaries of MTX1 were analyzed in 81 PD patient carriers of GBA mutations, 15 healthy controls that carry GBA mutations, and in 25 non-carrier patients. Among them, the MTX1 c.184T>A (p.S63T) variation was detected in 93% of GBA mutation carriers (both patients and healthy controls) and in 64% of non-carrier patients (p = 0.0008). This alteration was analyzed in 600 consecutively recruited Ashkenazi PD patients and in 353 controls, all genotyped for the LRRK2 p.G2019S and GBA founder mutations. A significantly higher frequency of the MTX1 c.184A allele was found in carriers of GBA mutations compared to non-carriers (0.67 and 0.45, respectively, p < 0.0001). The homozygous MTX1 c.184A/A genotype was associated with a significantly earlier age of motor symptoms onset in patients with GBA mutations compared to other groups of patients tested (5.1–5.9 years younger, p = 0.002–0.01). A significantly higher frequency of early-onset PD (<50 years) was detected among patients carrying both GBA mutation and the homozygous MTX1 c.184A/A genotype (35.9%, compared to 13.6–17.5%, p = 0.028). Our results raise the possibility that alteration on the opposite allele, which is in trans to the GBA mutant allele, may affect the clinical course of GBA-associated PD.

Keywords

Parkinson's disease GBA Glucocerebrosidase MTX1 

Supplementary material

10048_2011_293_MOESM1_ESM.doc (50 kb)
ESM 1(DOC 50 kb)

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Ziv Gan-Or
    • 1
    • 3
  • Anat Bar-Shira
    • 1
  • Tanya Gurevich
    • 2
    • 3
  • Nir Giladi
    • 2
    • 3
  • Avi Orr-Urtreger
    • 1
    • 3
  1. 1.The Genetic InstituteTel-Aviv Sourasky Medical CenterTel AvivIsrael
  2. 2.Movement Disorders Unit, Parkinson Center, Department of NeurologyTel-Aviv Sourasky Medical CenterTel-AvivIsrael
  3. 3.The Sackler Faculty of MedicineTel-Aviv UniversityTel-AvivIsrael

Personalised recommendations